Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) announced that Hunan Warner Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Notice of Approval of the Marketing Application for Chemical Ingredients” of arginine ibuprofen issued by the State Drug Administration and announced it on the “Registration Information Disclosure of Active Pharmaceutical Ingredients, Pharmaceutical Excipients and Pharmaceutical Packaging Materials” platform of the China Drug Administration (CDE) Drug Evaluation Center (CDE).

According to reports, arginine ibuprofen is an anti-inflammatory analgesic. It is mainly used for the following symptoms: toothache, dysmenorrhea, pain due to trauma (e.g. motor injury), joint and ligament pain, back pain, headache, and fever caused by influenza. Arginine ibuprofen inhibits prostaglandin synthesis and has analgesic, antipyretic and anti-inflammatory effects.